Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial-Reference-Cited by-同舟云学术

Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial

Published:2017-04-07 Issue:7 Volume:76 Page:1279-1284
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Burmester Gerd R,Rigby William F,van Vollenhoven Ronald F,Kay Jonathan^ORCID,Rubbert-Roth Andrea,Blanco Ricardo,Kadva Alysha,Dimonaco Sophie

Funder

F. Hoffmann-La Roche

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference13 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014

2. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis;Singh;Arthritis Care Res,2016

3. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial;Emery;Ann Rheum Dis,2008

4. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial;Smolen;Lancet,2008

5. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study;Genovese;Arthritis Rheum,2008

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy;Frontiers in Pharmacology;2024-08-13

2. Response to: Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?" by Studenicet al;Annals of the Rheumatic Diseases;2023-04-20

3. Randomized Clinical Trials on the Efficacy and Safety of Tocilizumab in Subjects with Rheumatoid Arthritis: A Systematic Review;Current Reviews in Clinical and Experimental Pharmacology;2023-03

4. Interleukin 6 Inhibition in Rheumatoid Arthritis: Highlight on Olokizumab;Rheumatology;2023

5. REVMATOİD ARTRİTİN MÜALİCƏSİNDƏ İL-6 ƏLEYHİNƏ MONOKLONAL ANTİCİSİMLƏRİN TƏTBİQİNİN PERSPEKTİVLƏRİ;Azerbaijan Medical Journal;2022-12-15